No abstract available
MeSH terms
-
Aged
-
Aged, 80 and over
-
Biomarkers
-
Combined Modality Therapy
-
Female
-
Humans
-
Janus Kinase 2 / genetics
-
Male
-
Middle Aged
-
Mutation
-
Pharmacogenomic Variants*
-
Primary Myelofibrosis / diagnosis*
-
Primary Myelofibrosis / drug therapy
-
Primary Myelofibrosis / genetics*
-
Prognosis
-
Protein Kinase Inhibitors / pharmacology
-
Protein Kinase Inhibitors / therapeutic use
-
Treatment Outcome
Substances
-
Biomarkers
-
Protein Kinase Inhibitors
-
JAK2 protein, human
-
Janus Kinase 2